About
Repurposing Existing Drugs
Areas of Focus
Categories
Small Molecule PharmaceuticalNJ, NY, PA
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
7
As Collaborator
1
Total Enrollment
1,034
By Phase
PHASE2: 4PHASE3: 2PHASE1: 2
By Status
COMPLETED: 6ACTIVE_NOT_RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05776004Lead Sponsor
Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial Pneumonia
PHASE2Active, not recruiting
276 participants
Started: Jul 22, 2023 · Completed: Sep 7, 2026
NCT03600376Lead Sponsor
Study to Assess the Efficacy and Safety of Ryanodex as Adjuvant Treatment in Subjects With EHS
PHASE3Completed
17 participants
Started: Aug 19, 2018 · Completed: Aug 14, 2019
NCT03324061Lead Sponsor
Study to Evaluate the Safety, Tolerability, and PK of Fulvestrant After IM Administration
PHASE1Completed
600 participants
Started: Nov 30, 2017 · Completed: Jul 12, 2018
NCT03189433Lead Sponsor
Efficacy and Safety Study of Ryanodex as Adjuvant Treatment in Subjects With Psychostimulant Drug-Induced Toxicity (PDIT)
PHASE2Terminated
2 participants
Started: Aug 12, 2017 · Completed: Dec 31, 2018
NCT02513095Lead Sponsor
Efficacy and Safety of Ryanodex® (EGL-4104) as Adjuvant Treatment in Subjects With Exertional Heat Stroke (EHS)
PHASE2Completed
34 participants
Started: Sep 30, 2015 · Completed: Oct 31, 2015
Locations (1)
Headquarters
Woodcliff Lake, NJ, United States
Map
Loading map...